LeonaBio, Inc. Common Stock LONA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $24.46M-54.5% | $17.5M-75.2% | $20.16M-76.3% | $35.26M-62.6% | $53.75M-42.7% | ||
| $18.33M-26.3% | $16.68M-36.1% | $19.11M-28.9% | $22.63M-16.6% | $24.88M-20.5% | ||
| $109.94M+32.9% | $102.27M+1.4% | $39.27M-65.7% | $62.01M-48.2% | $82.75M-32.9% | ||
| -$109.94M-32.9% | -$102.27M-1.4% | -$39.27M+65.7% | -$62.01M+48.2% | -$82.75M+32.9% | ||
| $1.43M-52.4% | $1.24M-68.8% | $1.54M-69.9% | $2.16M-65.8% | $3.01M-58.2% | ||
| -$129.41M-62.3% | -$105.61M-8.9% | -$37.72M+65.5% | -$59.85M+47.2% | -$79.75M+31.4% | ||
| -$22.49-56.6% | -$23.10-81.7% | -$8.06+15.7% | -$13.84-366% | -$14.36-371% | ||
| -$109.07M-33.2% | -$101.38M-1.4% | -$38.38M+66.2% | -$61.13M+48.6% | -$81.87M+33.1% | ||
| -$109.94M-32.9% | -$102.27M-1.4% | -$39.27M+65.7% | -$62.01M+48.2% | -$82.75M+32.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is LeonaBio, Inc. Common Stock profitable?
- LeonaBio, Inc. Common Stock is not currently profitable: it reported a net loss of $129.4M over the trailing twelve months.
- What is LeonaBio, Inc. Common Stock's earnings per share?
- LeonaBio, Inc. Common Stock's diluted EPS over the trailing twelve months is $-22.49.
- Where does LeonaBio, Inc. Common Stock's income statement data come from?
- Every line is extracted from LeonaBio, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.